4//SEC Filing
Winningham Rick E 4
Accession 0001415889-25-006684
CIK 0001583107other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:17 PM ET
Size
6.4 KB
Accession
0001415889-25-006684
Insider Transaction Report
Form 4
Winningham Rick E
DirectorChief Executive Officer
Transactions
- Award
Ordinary Shares
2025-02-28$9.35/sh+2,178$20,364→ 1,778,144 total
Holdings
- 3,900(indirect: As Custodian)
Ordinary Shares
- 92,567(indirect: By Trust)
Ordinary Shares
Footnotes (1)
- [F1]Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on February 28, 2025.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001302443
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:17 PM ET
- Size
- 6.4 KB